TWD
JANX icon

True Wealth Design’s Janux Therapeutics JANX Stock Holding History

True Wealth Design’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$87 Buy
+5
New +$84 ﹤0.01% 2459

Other funds holding JANX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return

True Wealth Design's JANX Position: Q3 2026 in Review

True Wealth Design opened a new position in Janux Therapeutics (JANX) in Q3 2026: 5 shares worth $87. The stake represents ﹤0.01% of the portfolio and ranks #2459 among its holdings.

6 funds tracked by Wall St. Rank hold JANX as of Q3 2026.

  • True Wealth Design held 5 shares of Janux Therapeutics worth $87 as of Q3 2026.
  • Janux Therapeutics was a new True Wealth Design position in Q3 2026.
  • Janux Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #2459 holding.
  • 6 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.